Data on the effectiveness of INI in the treatment of AD and other cognitive dysfunctions open up prospects for its use in the treatment of other pathologies, which are also, at least in part, due to functional changes in insulin signaling in the brain. The gene discussed is INS; the disease is Alzheimer disease.